NICE refuses Keytruda, Inlyta cancer combo
admin 12th February 2020 Uncategorised 0Despite evidence suggesting that the Keytruda combo would be welcomed by patients, NICE cites uncertainty around the long-term benefit.
More: NICE refuses Keytruda, Inlyta cancer combo
Source: News